Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells.

Item

http://www.wikidata.org/entity/Q39024419

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells.

@en

Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells.

@nl

type

Item

label

Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells.

@en

Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells.

@nl

prefLabel

Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells.

@en

Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells.

@nl

P1476

Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells.

@en

P2093

Fang-Yun Xu

http://www.w3.org/2001/XMLSchema#string

Hong-Mei Wang

http://www.w3.org/2001/XMLSchema#string

Xiao-Yan Zhou

http://www.w3.org/2001/XMLSchema#string

Yong-Hong Huang

http://www.w3.org/2001/XMLSchema#string

Zhen-Yu Cai

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor

Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors

Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent

Posttreatment with aspirin-triggered lipoxin A4 analog attenuates lipopolysaccharide-induced acute lung injury in mice: the role of heme oxygenase-1

Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor.

Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.

Lipoxin A4 stimulates calcium-activated chloride currents and increases airway surface liquid height in normal and cystic fibrosis airway epithelia.

Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators

P2888

s10753-014-9832-2

P304

1084-1090

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10753-014-9832-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24522831

http://www.w3.org/2001/XMLSchema#string

P921

NF-κB